Vertebral Compression Fracture Devices Market By Device Type (Vertebroplasty Devices, Kyphoplasty Devices, Other Devices), By Material Type (Bone Cement, Biodegradable Materials), By End-User (Hospitals, Orthopedic Clinics), and By Region; Global Insights & Forecast (2023 – 2030)

As per Intent Market Research, the Vertebral Compression Fracture Devices Market was valued at USD 1.2 billion in 2024-e and will surpass USD 2.3 billion by 2030; growing at a CAGR of 11.5% during 2025 - 2030.

Vertebral compression fractures (VCFs) typically occur in the spine as a result of osteoporosis, trauma, or other underlying conditions, leading to significant pain, disability, and in some cases, neurological damage. The use of vertebral compression fracture devices has gained traction in recent years as they provide effective solutions for stabilizing fractured vertebrae, reducing pain, and promoting the healing process. Vertebroplasty and kyphoplasty, the two primary treatment methods for VCFs, involve the injection of bone cement or other materials into fractured vertebrae, offering significant relief to patients.

The growing aging population, which is more prone to osteoporosis and fractures, combined with advancements in minimally invasive surgical techniques, is fueling the demand for vertebral compression fracture devices. With increasing awareness about spine health and the growing preference for outpatient, minimally invasive procedures, the market for these devices is expected to continue expanding.

Vertebroplasty Devices Lead the Market Owing to Widespread Use in Treating VCFs

Vertebroplasty devices are the leading type in the vertebral compression fracture devices market, largely due to their widespread use in the treatment of VCFs. Vertebroplasty involves the percutaneous injection of bone cement into fractured vertebrae, providing immediate relief from pain and restoring stability to the spine. This procedure is well-established and commonly used for treating painful vertebral compression fractures, especially in patients with osteoporosis. The simplicity of the procedure and the rapid recovery times make vertebroplasty an attractive option for both patients and healthcare providers, contributing to its dominance in the market.

The success rate of vertebroplasty in providing pain relief and improving mobility has driven its continued use, and ongoing improvements in bone cement technology are expected to further enhance the outcomes of this procedure, ensuring its position as the preferred treatment option for many patients.

Kyphoplasty Devices Gaining Popularity Owing to Their Enhanced Benefits in Restoring Vertebral Height

Kyphoplasty devices are gaining popularity as an advanced alternative to vertebroplasty due to their ability to restore vertebral height and provide more significant pain relief. Unlike vertebroplasty, kyphoplasty involves the insertion of a balloon into the fractured vertebra before injecting bone cement. The balloon inflates to restore the height of the vertebra, and the cement is then injected to stabilize the bone. This technique not only reduces pain but also helps prevent further collapse of the vertebra, offering long-term benefits for patients.

Kyphoplasty is particularly favored for patients with more severe fractures, as it addresses both pain management and vertebral height restoration. The increasing demand for kyphoplasty procedures is driving growth in the market, as it is seen as a more comprehensive solution for treating vertebral compression fractures.

Bone Cement is the Dominant Material Type Due to Its Efficacy in Stabilizing Fractures

Bone cement is the most commonly used material for vertebral compression fracture devices, owing to its proven efficacy in stabilizing fractured vertebrae. The use of bone cement in vertebroplasty and kyphoplasty procedures ensures that the vertebrae remain stable after the procedure, preventing further collapse and alleviating pain. Bone cement, typically composed of polymethyl methacrylate (PMMA), has been the standard material in these procedures for years due to its strength, durability, and biocompatibility.

The dominance of bone cement is expected to continue, though there is growing interest in alternative materials such as biodegradable materials, which could offer additional benefits, such as reducing the need for removal procedures or offering better integration with the body’s natural bone structure. The continued development of improved bone cement formulations will drive the growth of this material segment.

Hospitals Continue to Lead the End-User Segment Due to High Incidence of VCFs and Access to Advanced Surgical Technologies

Hospitals remain the largest end-user segment for vertebral compression fracture devices, largely due to the high incidence of VCFs and the need for advanced surgical technologies in a hospital setting. Hospitals are equipped with the necessary infrastructure to perform minimally invasive procedures such as vertebroplasty and kyphoplasty, and they are able to provide comprehensive care for patients, including post-procedure rehabilitation. The higher prevalence of VCFs in aging populations and the availability of specialized spine care centers within hospitals contribute to the continued dominance of this segment.

The ongoing advancement in surgical technologies and the increasing preference for outpatient surgeries also support the growth of this segment. Hospitals are expected to continue to account for the largest share of the market as they remain the primary healthcare providers for complex spine procedures.

North America Leads Due to High Incidence of Osteoporosis and Advanced Medical Infrastructure

North America is the leading region in the vertebral compression fracture devices market, primarily due to the high prevalence of osteoporosis and vertebral fractures, particularly among the aging population. The region's advanced healthcare systems, extensive research in orthopedic care, and the availability of innovative devices, such as vertebroplasty and kyphoplasty devices, contribute to its dominance. The increasing use of minimally invasive procedures also drives the demand for these devices.

In addition, North America’s strong healthcare regulations and the growing focus on improving treatment outcomes for bone fractures further strengthen its position as the largest market for vertebral compression fracture devices.

Leading Companies and Competitive Landscape

The leading companies in the vertebral compression fracture devices market include Medtronic, Stryker Corporation, and DePuy Synthes. Medtronic is a major player with its comprehensive portfolio of vertebroplasty and kyphoplasty devices, offering solutions that are widely used by healthcare providers globally. Stryker Corporation also holds a significant share, thanks to its advanced kyphoplasty devices and commitment to continuous innovation in spine care. DePuy Synthes, a subsidiary of Johnson & Johnson, is another key player in the market, offering a range of vertebral compression fracture treatment devices and having a strong global presence.

As competition intensifies, these companies are focusing on product innovation, strategic partnerships, and expanding their market reach. With the development of new materials and improvements in device design, they are well-positioned to maintain leadership in the growing vertebral compression fracture devices market.

Recent Developments:

• In February 2025, Medtronic announced the launch of an advanced kyphoplasty device aimed at improving patient recovery time.
• In January 2025, Stryker Corporation introduced a new bone cement formula to enhance the success of vertebroplasty procedures.
• In December 2024, Globus Medical unveiled a new vertebral compression fracture treatment device incorporating advanced imaging technologies.
• In November 2024, DePuy Synthes (Johnson & Johnson) received approval for a novel biodegradable implant designed for vertebral augmentation.
• In October 2024, Zimmer Biomet launched a new spinal surgery device for treating vertebral compression fractures with improved accuracy and efficiency.

List of Leading Companies:

• Medtronic plc
• Stryker Corporation
• Johnson & Johnson
• Zimmer Biomet Holdings, Inc.
• Boston Scientific Corporation
• DePuy Synthes (Johnson & Johnson)
• Smith & Nephew plc
• Globus Medical, Inc.
• NuVasive, Inc.
• Alphatec Spine, Inc.
• Spinal Elements, Inc.
• ATEC Spine, Inc.
• Orthofix Medical Inc.
• RTI Surgical Holdings, Inc.
• K2M, Inc.

Report Scope: